Insights

Pick Up the Pace on Patient Centricity

Aaron Mitchell, Lisa Bance, Kristyn Feldman and Nikita Reznik


> Download

Patients today are more empowered than ever to make informed healthcare decisions. As their healthcare influence grows—and they remain skeptical of treatment costs and mistrustful of the pharmaceutical industry—companies are gradually shifting toward patient centricity.

The industry’s treatment of patients needs to evolve from merely assigning ID numbers to including patients as active participants in their own healthcare. And with increasing complexity, cycle times and cost of clinical trials, it becomes even more imperative for pharmaceutical companies to put patients at the center of R&D.

In this article, ZS experts weigh in on the challenges of executing patient-centric initiatives and four strategies to overcome them.

About the Experts




Aaron Mitchell is the global lead for ZS’s R&D excellence practice, partnering with clients to strengthen the value of their pipelines, optimize the execution of clinical trials, drive the effective use of real-world evidence, and improve medical and scientific engagement. A key area of focus for Aaron is patient-centric drug development, including optimizing clinical trials for patients and leveraging real-world evidence to support product development.




Lisa Bance leads life cycle evidence strategy and R&D excellence at ZS, partnering with pharmaceutical clients to drive evidence-based strategy, design, analytics and insights from early commercialization to product maturity. With more than 25 years of experience in the pharmaceutical industry, Lisa has served leadership roles in global marketing and product development, CRO phase IV and translational research strategy, early commercialization consulting and medical communications.




Kristyn Feldman is an associate consultant within the R&D excellence practice. Her work focuses on patientcentric drug development, leveraging her background in clinical research to define and develop a growing suite of innovative products and consulting services for R&D clients. Kristyn joined ZS after completing her postdoctoral fellowship at the University of California, San Francisco, during which she traveled to Kenya to manage clinical trials with HIV patients. She holds a Ph.D. in biomedical science from University of California, San Diego.




Nikita Reznik is an associate consultant within ZS’s R&D excellence practice. His work involves patientcentric research, quantitative modeling and real-world evidence analytics. With more than seven years of R&D experience in the fields of biotechnology and medical devices, Nikita supports pipeline product development, focusing on oncology, neuroscience and cardiovascular diseases. He holds a Ph.D. in medical biophysics from the University of Toronto.